Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals is a speciality pharmaceutical formulation Company engaged in the development, manufacture and marketing of quality finished dosages.(Source : 201903 Annual Report Page No: 08)

  • Market Cap: 175.22 Cr.
  • Current Price: 381.80
  • 52 weeks High / Low 559.00 / 243.20
  • Book Value: 168.78
  • Stock P/E: 10.22
  • Dividend Yield: 2.67 %
  • ROCE: 36.95 %
  • ROE: 28.57 %
  • Sales Growth (3Yrs): 9.43 %
  • Listed on BSE
  • Company Website
  • Face Value: 10.00
Edit ratios
Pros:
Company is virtually debt free.
Company has good consistent profit growth of 21.45% over 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 28.89%
Company has been maintaining a healthy dividend payout of 25.18%
Cons:
The company has delivered a poor growth of 9.98% over past five years.
Debtor days have increased from 46.70 to 68.12 days.

Peer comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Formulations

Loading peers table ...

Quarterly Results Figures in Rs. Crores

Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019
27 17 37 31 30 23 32 32 35 21 34 34
22 21 24 24 22 21 25 26 26 21 27 27
Operating Profit 6 -4 12 6 9 3 7 6 9 -1 7 7
OPM % 21% -21% 34% 21% 28% 11% 22% 20% 25% -3% 22% 20%
Other Income 1 1 1 1 1 1 1 1 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 1 1 1
Profit before tax 6 -3 13 7 9 3 8 7 9 0 8 7
Tax % 41% 1% 23% 32% 35% 13% 24% 32% 27% -200% 26% 30%
Net Profit 4 -3 10 5 6 3 6 4 7 0 6 5
EPS in Rs 7.60 -6.19 21.45 9.89 12.15 5.88 12.52 9.72 15.02 0.13 12.10 10.11
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Figures in Rs. Crores

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
38 42 51 57 60 69 76 85 94 103 115 123 124
35 38 45 47 50 59 65 70 77 84 91 98 101
Operating Profit 3 4 6 10 10 10 12 15 16 20 24 25 22
OPM % 9% 9% 13% 18% 16% 14% 15% 18% 18% 19% 21% 20% 18%
Other Income 0 0 1 0 1 1 2 2 3 3 3 3 4
Interest 1 1 1 1 1 1 1 0 0 0 0 0 0
Depreciation 1 1 1 1 1 1 2 3 2 2 2 1 2
Profit before tax 2 3 6 9 9 9 10 14 17 20 25 27 24
Tax % 40% 44% 34% 34% 30% 30% 27% 33% 36% 34% 32% 26%
Net Profit 1 2 4 6 6 6 8 10 11 14 17 20 17
EPS in Rs 2.58 3.20 7.61 12.37 12.30 12.69 15.32 19.47 21.72 29.05 37.50 43.14 37.36
Dividend Payout % 45% 51% 37% 27% 27% 31% 32% 30% 31% 28% 24% 24%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:11.20%
5 Years:9.98%
3 Years:9.43%
TTM:5.24%
Compounded Profit Growth
10 Years:28.30%
5 Years:21.45%
3 Years:22.51%
TTM:-7.25%
Stock Price CAGR
10 Years:18.95%
5 Years:1.19%
3 Years:-10.95%
1 Year:-27.26%
Return on Equity
10 Years:30.79%
5 Years:29.31%
3 Years:28.89%
Last Year:28.57%

Balance Sheet Figures in Rs. Crores

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Sep 2019
5 5 5 5 5 5 5 5 5 5 5 5 5
Reserves 3 4 6 10 14 18 23 29 36 50 57 73 73
Borrowings 10 7 5 2 2 5 2 7 5 6 0 7 5
8 11 11 19 19 22 15 21 12 16 16 18 19
Total Liabilities 26 26 27 36 40 49 44 61 58 76 77 103 102
6 6 7 10 13 14 14 12 12 11 10 10 12
CWIP 0 1 1 1 0 0 0 0 0 0 0 1 0
Investments 0 0 1 1 1 0 0 0 1 2 5 5 5
19 18 18 24 26 34 30 49 45 64 62 87 84
Total Assets 26 26 27 36 40 49 44 61 58 76 77 103 102

Cash Flows Figures in Rs. Crores

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
1 4 5 7 7 5 11 9 8 10 16 13
-0 -1 -1 -3 -3 -1 0 1 -0 -10 1 -11
-0 -4 -4 -2 -2 0 -7 1 -5 1 -18 -2
Net Cash Flow 0 -0 0 2 2 3 5 11 2 1 -1 0

Ratios Figures in Rs. Crores

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 19% 24% 42% 60% 48% 40% 41% 42% 40% 39% 42% 37%
Debtor Days 48 31 27 31 22 32 26 32 23 32 40 68
Inventory Turnover 2.46 2.65 3.47 3.57 3.26 3.26 3.59 3.68 3.50 3.22 3.87 4.36